Resources

Type of publications
Regions
Diseases
4906 results found
2025 ∙ Naderian, R. Eslami, M. Ahmad, S. Paraandavaji, E. Yaghmayee, S. Soltanipur, M. Naderian, R. Pajand, O. Tajdini, P. Alizadeh, A. Sanami, S.
Efficacy, Immune Response, and Safety of Dengue Vaccines in Adolescents: A Systematic Review
Adolescents Dengue Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Wang, Y. Zhang, Y. Wang, J. Shi, N. Jin, H.
Enhancing influenza vaccination uptake: a systematic review and meta-analysis of intervention strategies
All age groups Pregnant women Healthcare workers Influenza Coverage
Rating:
Not applicable
2025 ∙ Liu, J. Zhang, Y. Zhang, H. Tan, H.
Estimating the effects of interventions on increasing vaccination: systematic review and meta-analysis
All age groups Coverage
Rating:
Not applicable
2025 ∙ Szondy, I. Lorincz, K. Walter, A. Mohammed, A. A. Hegyi, P. Kiss, N. Meznerics, F. A. Banvolgyi, A.
Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis
All age groups Meningococcal disease Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.
Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis
Adolescents Adults Hepatitis E Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Siddiqui, E. Khan, M. S. Khalid, M. Chandani, H. K. Naeem, U. Khan, M. M. Wasti, S. O.
Evaluating the immunogenicity and safety of ID93 + GLA-SE in BCG-vaccinated healthy adults: a systematic review and meta-analysis of randomized controlled trials
Adults Tuberculosis Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Williams, L. R. Hombach, J. Marti, M.
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
All age groups Herpes zoster Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Zadeh Mehrizi, T. Eshrati, B. Ebrahimi Shahmabadi, H.
Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review
All age groups Hepatitis B Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Sterian, M. Naganathan, T. Corrin, T. Waddell, L.
Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Larson, A. Shanmugam, P. Mitrovich, R. Vohra, D. Lansdale, A. J. Eiden, A. L.
Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies
All age groups Coverage
Rating:
Not applicable
Loading...